Analyst and Research & Development Day to be held in New York on November 10 at 8:30 am. Webcast Link
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on VAXX:
- Vaxxinity to hold analyst and research and development day
- Vaxxinity to Present at Upcoming Investor Conferences in November
- Vaxxinity completes enrollment in Phase 3 trial of UB-612
- Vaxxinity Announces First Subjects Dosed in Phase 1 Clinical Trial of UB-313 for Preventive Treatment of Migraine
- Vaxxinity announces first subjects dosed in Phase 1 trial of UB-313